1.1 Maternal, Obstetric & Perinatal History

Key Takeaways

  • Maternal diabetes increases neonatal hypoglycemia, hypertrophic cardiomyopathy, macrosomia, and respiratory-distress risk. Fetal-lung-maturity tests are imperfect and should not replace assessment of gestational age, symptoms, and the full perinatal picture.
  • A low biophysical profile is concerning for fetal compromise and requires prompt obstetric evaluation; the score must be interpreted with gestational age, individual components, fetal monitoring, and maternal status.
  • Prolonged rupture of membranes, maternal fever or suspected intra-amniotic infection, prematurity, and inadequate group-B-streptococcus prophylaxis are important early-onset sepsis risk factors.
Last updated: September 2026

1.1 Maternal, Obstetric & Perinatal History

Neonatal assessment begins long before the infant takes its first breath. For the neonatal and pediatric respiratory therapist, comprehensive knowledge of maternal medical history, obstetric complications, and prenatal diagnostic testing is critical for predicting delivery room resuscitation requirements and anticipating acute neonatal pulmonary pathophysiology.


Gravida and Para: The Obstetric Foundation

A woman's obstetric history is traditionally communicated using the Gravida/Para designation or the more granular TPAL classification system:

  • Gravida (G): The total number of confirmed pregnancies, regardless of gestational duration or clinical outcome, including the current pregnancy.
  • Para (P): The number of pregnancies that have reached viable gestational age (traditionally $\ge 20$ weeks or a fetal weight $\ge 500\text{ g}$ credit), regardless of whether the fetus was born alive or stillborn. Multiple gestations (e.g., twins or triplets) count as a single parous delivery event.

The TPAL system breaks Para down into four distinct categories (G_ P_T_P_A_L_):

  1. T (Term deliveries): Births occurring at $\ge 37\text{ weeks}$ gestation.
  2. P (Preterm deliveries): Births occurring between $20\text{ weeks}$ and $36\text{ weeks and } 6\text{ days}$ gestation.
  3. A (Abortions): Pregnancies terminating prior to $20\text{ weeks}$ gestation, encompassing spontaneous miscarriages and induced or therapeutic terminations.
  4. L (Living children): The current count of living biological children.

Clinical Significance for the Neonatal Specialist

  • Grand Multiparity ($\ge 5$ deliveries): Carries an increased risk of uterine atony, postpartum maternal hemorrhage, precipitous labor, placental abruption, and fetal malpresentation, increasing the likelihood of intrapartum fetal hypoxia.
  • Prior Preterm Delivery: A history of a prior preterm birth is the single strongest clinical predictor of recurrent preterm labor. When PPROM raises the likelihood of preterm delivery, prepare gestation-appropriate stabilization and respiratory equipment while also anticipating infection, cord, fluid, and pulmonary-development complications.
  • Maternal Age Extremes: Adolescent mothers ($<18\text{ years}$) face elevated risks of pregnancy-induced hypertension, premature delivery, low birth weight, and cephalopelvic disproportion. Advanced maternal age ($>35\text{ years}$) is strongly correlated with gestational diabetes, chronic maternal vascular disease, preeclampsia, placenta previa, and chromosomal aneuploidies (e.g., Trisomy 21).
  • Lack of Prenatal Care: Unmonitored pregnancies have a threefold higher incidence of low birth weight and a fivefold increase in neonatal mortality, frequently presenting with undetected maternal infections, structural anomalies, and unmanaged metabolic derangements.

Maternal Medical Conditions & Neonatal Pathophysiology

Maternal ComplicationPrimary PathophysiologyImpact on Fetal DevelopmentNeonatal Complications & Delivery Room Action
Gestational Diabetes (GDM) / IDMMaternal hyperglycemia $\rightarrow$ fetal hyperglycemia $\rightarrow$ fetal hyperinsulinemia (Pedersen hypothesis)Macrosomia (LGA, weight $>90\text{th}$ percentile), organomegaly, delayed pulmonary maturitySurfactant deficiency/RDS (insulin inhibits cortisol-mediated surfactant apoprotein synthesis), profound hypoglycemia, polycythemia, shoulder dystocia/phrenic nerve injury.
Preeclampsia / PIHSystemic endothelial dysfunction, abnormal spiral artery remodeling, generalized vasospasmChronic uteroplacental insufficiency, chronic fetal hypoxia, asymmetric IUGR, oligohydramniosPreterm delivery, placental abruption. Neonatal hypermagnesemia from maternal $\text{MgSO}_4$ infusion $\rightarrow$ hypotonia, apnea, and respiratory depression.
ChorioamnionitisPolymicrobial bacterial invasion of amniotic fluid, chorion, and amnion (ascending genital tract flora)Fetal inflammatory response syndrome (FIRS), intra-amniotic cytokine storm, funisitisEarly-onset neonatal sepsis (EONS), septic shock, congenital pneumonia, Persistent Pulmonary Hypertension of the Newborn (PPHN), severe RDS.
Maternal Opioid UseChronic transplacental passage of synthetic or natural opioids with fetal neuroreceptor bindingFetal growth restriction, chronic intrauterine hypoxia, intermittent withdrawal episodesNeonatal Abstinence Syndrome (NAS): hypertonia, tremors, tachypnea with respiratory alkalosis, autonomic dysregulation, feeding intolerance.

Gestational Diabetes Mellitus (GDM) & The Infant of a Diabetic Mother (IDM)

Maternal hyperglycemia results in excessive glucose transfer across the placenta. In response, the fetal pancreas produces excessive insulin (Pedersen hypothesis). Because insulin is the primary anabolic growth hormone in utero, the fetus develops macrosomia (Large for Gestational Age, birth weight $>4,000\text{ g}$ or $>90\text{th}$ percentile) with excessive subcutaneous fat deposition across the shoulders and trunk.

From a pulmonary perspective, fetal hyperinsulinemia directly antagonizes the stimulatory effect of endogenous cortisol on fetal type II pneumocytes. Insulin inhibits the transcription and synthesis of surfactant-associated proteins (SP-A and SP-B) and blocks the incorporation of choline into dipalmitoylphosphatidylcholine (DPPC). Consequently, IDM infants are at substantial risk for severe Respiratory Distress Syndrome (RDS), even when delivered near term (37–38 weeks).

Other critical IDM sequelae include:

  • Postnatal Hypoglycemia: Cord clamping abruptly eliminates maternal glucose transfer while neonatal hyperinsulinism persists, precipitating a precipitous drop in blood glucose ($<40\text{ mg/dL}$ in the first 4 hours or $<45\text{ mg/dL}$ thereafter). Severe hypoglycemia impairs cerebral metabolism and blunts diaphragmatic contractility.
  • Polycythemia & Hyperviscosity: Chronic fetal tissue hypoxia drives fetal erythropoietin secretion, raising venous hematocrit above $65%$. Hyperviscosity impairs microvascular perfusion, predisposing the neonate to renal vein thrombosis and exacerbating pulmonary vascular resistance (PVR).
  • Hypertrophic Cardiomyopathy: Transient asymmetric septal hypertrophy can produce subaortic left ventricular outflow tract obstruction, worsening cardiogenic pulmonary edema.
  • Birth Trauma: Shoulder dystocia frequently causes brachial plexus traction injuries (Erb palsy, C5–C6) and phrenic nerve injury (C3–C5), resulting in diaphragmatic paralysis and asymmetric thoracic excursion that mimics severe unilateral atelectasis.

Preeclampsia, PIH, and Maternal Magnesium Sulfate

Preeclampsia is characterized by new-onset hypertension (systolic $\ge 140\text{ mmHg}$ or diastolic $\ge 90\text{ mmHg}$) after 20 weeks gestation accompanied by proteinuria ($\ge 300\text{ mg/24 hr}$) or signs of maternal end-organ damage (thrombocytopenia, hepatic transaminitis, pulmonary edema, cerebral/visual disturbances). The underlying vascular dysfunction causes progressive placental infarction, reducing oxygen and nutrient delivery to the fetus, which culminates in Intrauterine Growth Restriction (IUGR) and oligohydramnios.

Interestingly, chronic intrauterine stress and placental ischemia stimulate fetal endogenous adrenal corticosteroid release, which can paradoxically accelerate fetal surfactant synthesis in some growth-restricted fetuses. However, when maternal magnesium sulfate ($\text{MgSO}_4$) is infused for maternal seizure prophylaxis, magnesium readily crosses the placenta. The neonate cannot clear magnesium rapidly due to immature glomerular filtration. Neonatal hypermagnesemia antagonizes calcium at neuromuscular junctions, presenting in the delivery room as:

  • Severe flaccid hypotonia
  • Weak or absent spontaneous respiratory effort (apnea)
  • Lethargy and hyporeflexia
  • Poor suck and impaired deglutition

Chorioamnionitis and Intra-Amniotic Infection

Chorioamnionitis is an acute inflammation of the fetal membranes and chorion, typically triggered by ascending genital bacteria following Prolonged Rupture of Membranes (PROM $>18\text{ hours}$). Clinical diagnostic criteria include:

  • Maternal fever (temperature $\ge 38.0^\circ\text{C}$ / $100.4^\circ\text{F}$)
  • Maternal leukocytosis ($>15,000/\mu\text{L}$)
  • Maternal tachycardia ($>100\text{ bpm}$) and persistent fetal tachycardia ($>160\text{ bpm}$)
  • Uterine fundal tenderness and purulent, foul-smelling amniotic fluid

Fetal aspiration of infected amniotic fluid leads directly to congenital pneumonia, alveolar destruction, and Early-Onset Neonatal Sepsis (EONS), most commonly caused by Group B Streptococcus (GBS), Escherichia coli, and Listeria monocytogenes. Inflammatory mediators provoke intense pulmonary vasoconstriction, precipitating Persistent Pulmonary Hypertension of the Newborn (PPHN) with refractory hypoxemia and right-to-left extrapulmonary shunting.

Maternal Substance Exposure & Neonatal Abstinence Syndrome (NAS)

Transplacental exposure to maternal substances significantly alters neonatal cardiopulmonary and neurobehavioral stability:

  • Opioids (Heroin, Methadone, Buprenorphine, Oxycodone): Discontinuation of maternal supply causes Neonatal Abstinence Syndrome (NAS), usually emerging within 24 to 72 hours for short-acting opioids, or 5 to 7 days for methadone. Manifestations are quantified using the modified Finnegan Neonatal Abstinence Scoring Tool and include high-pitched continuous crying, severe tremors, hypertonicity, frantic uncoordinated sucking, vomiting, watery diarrhea, and tachypnea ($>60\text{ breaths/min}$). The tachypnea is centrally mediated by opioid withdrawal and typically induces a respiratory alkalosis rather than primary parenchymal lung pathology.
  • Cocaine & Amphetamines: Potent maternal and placental vasoconstrictors. They induce acute fetal hypoxia, placental abruption, intrauterine growth restriction, microcephaly, and an elevated incidence of necrotizing enterocolitis (NEC).
  • Tobacco / Nicotine: Carbon monoxide elevates fetal carboxyhemoglobin, displacing oxygen from fetal hemoglobin, while nicotine constricts uterine arteries. This causes chronic placental insufficiency, low birth weight, and a threefold higher risk of Sudden Infant Death Syndrome (SIDS).

Test Your Knowledge

A 36-year-old gravida 3, para 2 woman with poorly controlled gestational diabetes delivers a 4,300 g infant at 37 weeks gestation. Amniocentesis performed 24 hours prior to delivery revealed an L/S ratio of 2.2 and absent phosphatidylglycerol (PG). At 20 minutes of life, the neonate displays marked tachypnea (respiratory rate 82 breaths/min), intercostal retractions, and expiratory grunting on room air. What is the underlying pathophysiology of this infant's respiratory distress despite an L/S ratio exceeding 2.0?

A
B
C
D
Test Your Knowledge

A primigravida at 38 weeks gestation with severe preeclampsia received an intravenous magnesium sulfate infusion for 30 hours prior to an urgent cesarean delivery. At birth, the newborn presents with severe flaccid hypotonia, absent spontaneous respiratory effort, a heart rate of 115 bpm, and sluggish pupillary responses. After drying, warming, and stimulating, the infant remains apneic. Which of the following is the most appropriate next step in management?

A
B
C
D